VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESGO 2021 | Importance of real-world data on patient outcomes

Vimalanand Prabhu, PhD, Merck, Lansdale, PA, discusses possible sources and uses of real-world data, and compares this style of study to randomized clinical trials. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.

Disclosures

Vimalanand Prabhu is an employee of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA and shareholder of Merck & Co., Inc., Kenilworth, NJ, USA.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter